NEW YORK , July 26, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Alimera Sciences, Inc. (NASDAQ: ALIM)'s sale to ANI Pharmaceuticals, Inc. for $5.
50 per share in cash at closing and one non-tradable contingent value right representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027. If you are an Alimera shareholder, click here to learn more about your rights and options .
Doma Holdings, Inc. (NYSE: DOMA)'s sale to Title Resources Group for $6.29 per share.
If you are a Doma shareholder, click here to learn more about your rights and options . Calliditas Therapeutics AB (NASDAQ: CALT)'s sale to Asahi Kasei Corporation for SEK 416 in cash per American Depositary Share. If you are a Calliditas shareholder, click here to learn more about your legal rights and options .
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options.
Please call Daniel S.